PROSER1 and hematologic disorder: Our work sets the stage for further investigations focusing on how PROSER1 deficiency and the subsequent dysregulation of DNA methylation may affect the function of terminally differentiated blood cells, as well as its contribution and potential synergy with other oncogenic hits toward the development of hematological diseases.